Invivyd, Inc. (IVVD)
NASDAQ: IVVD · Real-Time Price · USD
0.9699
+0.0387 (4.16%)
At close: Jun 18, 2026, 4:00 PM EDT
0.9799
+0.0100 (1.03%)
After-hours: Jun 18, 2026, 7:59 PM EDT
Invivyd Market Cap
Invivyd has a market cap or net worth of $285.74 million as of June 18, 2026. Its market cap has increased by 145.79% in one year.
Market Cap
285.74M
Enterprise Value
110.21M
1-Year Change
145.79%
Ranking
Category
Stock Price
$0.97
Market Cap Chart
Since August 6, 2021, Invivyd's market cap has decreased from $2.27B to $285.74M, a decrease of -87.39%. That is a compound annual growth rate of -34.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 285.74M | -58.26% |
| Dec 31, 2025 | 684.49M | 1,191.45% |
| Dec 31, 2024 | 53.00M | -87.78% |
| Dec 29, 2023 | 433.85M | 165.40% |
| Dec 30, 2022 | 163.47M | -79.76% |
| Dec 31, 2021 | 807.69M | -64.36% |
| Aug 6, 2021 | 2.27B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DiaMedica Therapeutics | 309.83M |
| Palisade Bio | 308.90M |
| OmniAb | 302.27M |
| Lyell Immunopharma | 297.39M |
| Inhibikase Therapeutics | 296.53M |
| Eledon Pharmaceuticals | 293.75M |
| Cartesian Therapeutics | 287.94M |
| SAB Biotherapeutics | 281.10M |